In vitro and in vivo efficacy of novel flavonoid dimers against cutaneous leishmaniasis

Antimicrobial Agents and Chemotherapy

Volumn 58, Issue 6, 2014, Pages 3379-3388

  Wong, Iris L K ^a,b   Chan, Kin Fai ^a,b   Chen, Yun Fu ^c   Lun, Zhao Rong ^d   Chan, Tak Hang ^a,b,c   Chow, Larry M C ^a,b  

^a HONG KONG POLYTECHNIC UNIVERSITY   (Hong Kong)

^b State Key Laboratory in Chinese Medicine and Molecular Pharmacology   (China)

^c State Key Laboratory of Tropical Oceanography   (China)

^d MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; ANTILEISHMANIAL AGENT; DIMER; FLAVONOID; MILTEFOSINE; PENTAMIDINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIPROTOZOAL ACTIVITY; ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; DRUG EFFICACY; FEMALE; FOOT PAD; IC 50; IN VITRO STUDY; IN VIVO STUDY; INOCULATION; LEISHMANIA; LEISHMANIA BRAZILIENSIS; LEISHMANIA MAJOR; LEISHMANIA MEXICANA; LEISHMANIA TROPICA; MOUSE; NONHUMAN; PARASITE LOAD; PERITONEUM MACROPHAGE; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; SKIN LEISHMANIASIS; ANIMAL; BAGG ALBINO MOUSE; CHEMISTRY; DISEASE MODEL; DRUG EFFECTS; IC50; LEISHMANIASIS, CUTANEOUS;

ANIMALS; DISEASE MODELS, ANIMAL; FEMALE; FLAVONOIDS; INHIBITORY CONCENTRATION 50; LEISHMANIA; LEISHMANIASIS, CUTANEOUS; MICE; MICE, INBRED BALB C;

EID: 84901254085     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.02425-13     Document Type: Article

References (26)

1. Alvar J, Velez ID, Bern C, Herrero M, Desjeux P, Cano J, Jannin J, den Boer M. 2012. Leishmaniasis worldwide and global estimates of its incidence. PLoS One 7:e35671. http://dx.doi.org/10.1371/journal.pone.0035671.
2. Reithinger R, Dujardin J-C, Louzir H, Pirmez C, Alexander B, Brooker S. 2007. Cutaneous leishmaniasis. Lancet Infect. Dis. 7:581-596. http://dx.doi.org/10.1016/S1473-3099(07)70209-8.
3. González U, Pinart M, Reveiz L, Rengifo-Pardo M, Tweed J, Macaya A, Alvar J. 2010. Designing and reporting clinical trials on treatments for cutaneous leishmaniasis. Clin. Infect. Dis. 51:409-419. http://dx.doi.org/10. 1086/655134.
4. Sundar S, Chakravarty J. 2013. Leishmaniasis: an update of current pharmacotherapy. Expert Opin. Pharmacother. 14:53-63. http://dx.doi.org/10.1517/ 14656566.2013.755515.
5. Berman JD. 1997. Human leishmaniasis: clinical, diagnostic, and chemotherapeutic developments in the last 10 years. Clin. Infect. Dis. 24:684-703. http://dx.doi.org/10.1093/clind/24.4.684.
6. Desjeux P. 2004. Leishmaniasis: current situation and new perspectives. Comp. Immunol. Microbiol. Infect. Dis. 27:305-318. http://dx.doi.org/10.1016/j. cimid.2004.03.004.
7. Mishra J, Saxena A, Singh S. 2007. Chemotherapy of leishmaniasis: past, present and future. Curr. Med. Chem. 14:1153-1169. http://dx.doi.org/10.2174/ 092986707780362862.
8. Mishra BB, Tiwari VK. 2011. Natural products: an evolving role in future drug discovery. Eur. J. Med. Chem. 46:4769-4807. http://dx.doi.org/10.1016/j. ejmech.2011.07.057.
9. Harborne JB, Williams CA. 2000. Advances in flavonoid research since 1992. Phytochemistry 55:481-504. http://dx.doi.org/10.1016/S0031-9422 (00)00235-1.
10. Kayser O, Kiderlen AF, Croft SL. 2003. Natural products as antiparasitic drugs. Parasitol. Res. 90(Suppl 2):S55-S62. http://dx.doi.org/10.1007/s00436- 002-0768-3.
11. Salem MM, Werbovetz KA. 2006. Natural products from plants as drug candidatesandleadcompoundsagainstleishmaniasisandtrypanosomiasis. Curr.Med. Chem. 13:2571-2598. http://dx.doi.org/10.2174/092986706778201611.
12. Singh N, Mishra BB, Bajpai S, Singh RK, Tiwari VK. 2014. Natural product based leads to fight against leishmaniasis. Bioorg. Med. Chem. 22:18-45. http://dx.doi.org/10.1016/j.bmc.2013.11.048.
13. Chan KF, Wong IL, Kan JW, Yan CS, Chow LM, Chan TH. 2012. Amine linked flavonoid dimers as modulators for P-glycoprotein-based multidrug resistance: structure-Activity relationship and mechanism of modulation. J. Med. Chem. 55:1999-2014. http://dx.doi.org/10.1021/jm201121b.
14. Chan KF, Zhao Y, Burkett BA, Wong IL, Chow LM, Chan TH. 2006. Flavonoid dimers as bivalent modulators for P-glycoprotein-based multidrug resistance: synthetic apigenin homodimers linked with definedlength poly(ethylene glycol) spacers increase drug retention and enhance chemosensitivity in resistant cancer cells. J. Med. Chem. 49:6742-6759. http://dx.doi.org/10.1021/jm060593-.
15. Chan KF, Zhao Y, Chow TW, Yan CS, Ma DL, Burkett BA, Wong IL, Chow LM, Chan TH. 2009. Flavonoid dimers as bivalent modulators for P-glycoprotein-based multidrug resistance: structure-Activity relationships. ChemMed-Chem 4:594-614. http://dx.doi.org/10.1002/cmdc.200800413.
16. Wong IL, Chan KF, Burkett BA, Zhao Y, Chai Y, Sun H, Chan TH, Chow LM. 2007. Flavonoid dimers as bivalent modulators for pentamidine and sodium stiboglucanate resistance in Leishmania. Antimicrob. Agents Chemother. 51:930-940. http://dx.doi.org/10.1128/AAC.00998-06.
17. Wong IL, Chan KF, Tsang KH, Lam CY, Zhao Y, Chan TH, Chow LM. 2009. Modulation of multidrug resistance protein 1 (MRP1/ABCC1)-mediated multidrug resistance by bivalent apigenin homodimers and their derivatives. J. Med. Chem. 52:5311-5322. http://dx.doi.org/10.1021/jm900194w.
18. Wong IL, Chan KF, Zhao Y, Chan TH, Chow LM. 2009. Quinacrine and a novel apigenin dimer can synergistically increase the pentamidine susceptibility of the protozoan parasite Leishmania. J. Antimicrob. Chemother. 63:1179-1190. http://dx.doi.org/10.1093/jac/dkp130.
19. Wong IL, Chan KF, Chan TH, Chow LM. 2012. Flavonoid dimers as novel, potent antileishmanial agents. J. Med. Chem. 55:8891-8902. http://dx.doi.org/10. 1021/jm301172v.
20. Chow LM, Wong AK, Ullman B, Wirth DF. 1993. Cloning and functional analysis of an extrachromosomally amplified multidrug resistancelike gene in Leishmania enriettii. Mol. Biochem. Parasitol. 60:195-208. http://dx.doi.org/10. 1016/0166-6851(93)90131-G.
21. Weniger B, Vonthron-Senecheau C, Kaiser M, Brun R, Anton R. 2006. Comparative antiplasmodial, leishmanicidal and antitrypanosomal activities of several biflavonoids. Phytomedicine 13:176-180. http://dx.doi.org/10.1016/j. phymed.2004.10.008.
22. Tasdemir D, Kaiser M, Brun R, Yardley V, Schmidt TJ, Tosun F, Ruedi P. 2006. Antitrypanosomal and antileishmanial activities of flavonoids and their analogues: in vitro, in vivo, structure-Activity relationship, and quantitative structure-Activity relationship studies. Antimicrob. Agents Chemother. 50:1352-1364. http://dx.doi.org/10.1128/AAC.50.4.1352-1364.2006.
23. da Silva ER, Maquiaveli Cdo C, Magalhaes PP. 2012. The leishmanicidal flavonols quercetin and quercitrin target Leishmania (Leishmania) amazonensis arginase. Exp. Parasitol. 130:183-188. http://dx.doi.org/10.1016/j.exppara.2012. 01.015.
24. Fonseca-Silva F, Inacio JD, Canto-Cavalheiro MM, Almeida-Amaral EE. 2011. Reactive oxygen species production and mitochondrial dysfunction contribute to quercetin induced death in Leishmania amazonensis. PLoS One 6:e14666. http://dx.doi.org/10.1371/journal.pone.0014666.
25. Mittra B, Saha A, Chowdhury AR, Pal C, Mandal S, Mukhopadhyay S, Bandyopadhyay S, Majumder HK. 2000. Luteolin, an abundant dietary component is a potent anti-leishmanial agent that acts by inducing topoisomerase II-mediated kinetoplast DNA cleavage leading to apoptosis. Mol. Med. 6:527-541. http://dx.doi.org/10.1007/s0089400060527.
26. Sen G, Mukhopadhyay S, Ray M, Biswas T. 2008. Quercetin interferes with iron metabolism in Leishmania donovani and targets ribonucleotide reductase to exert leishmanicidal activity. J. Antimicrob. Chemother. 61: 1066-1075. http://dx.doi.org/10.1093/jac/dkn053.